Comparison of melphalan-prednisone (MP) to MP plus thalidomide in the treatment of newly diagnosed very elderly patients (greater than 75 years) with multiple myeloma

Trial Profile

Comparison of melphalan-prednisone (MP) to MP plus thalidomide in the treatment of newly diagnosed very elderly patients (greater than 75 years) with multiple myeloma

Completed
Phase of Trial: Phase III

Latest Information Update: 10 May 2009

At a glance

  • Drugs Melphalan; Prednisone; Thalidomide
  • Indications Multiple myeloma
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 10 May 2009 Results published in Journal of Clinical Oncology.
    • 09 Dec 2007 Status change from in progress to completed.
    • 12 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top